07:00 , Sep 15, 2014 |  BC Week In Review  |  Company News

Ligand, Avion deal

Ligand granted Avion undisclosed development and commercialization rights to four undisclosed programs using Ligand's Captisol formulation technology. Ligand will receive an undisclosed upfront payment and be eligible for milestones and royalties. Ligand said it will...